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Chlamydia trachomatis (Ct) constitutes the most prevalent sexually
transmitted bacteriumworldwide. Chlamydial infections can lead to
severe clinical sequelae including pelvic inflammatory disease, ec-
topic pregnancy, and tubal infertility. As an obligate intracellular
pathogen, Ct has evolved multiple strategies to promote adhesion
and invasion of host cells, including those involving both bacterial
and host glycans. Here, we show that galectin-1 (Gal1), an endog-
enous lectin widely expressed in female and male genital tracts,
promotes Ct infection. Through glycosylation-dependent mecha-
nisms involving recognition of bacterial glycoproteins and N-glyco-
sylated host cell receptors, Gal1 enhanced Ct attachment to cervical
epithelial cells. Exposure to Gal1, mainly in its dimeric form, facili-
tated bacterial entry and increased the number of infected cells by
favoring Ct–Ct and Ct–host cell interactions. These effects were sub-
stantiated in vivo in mice lacking Gal1 or complex β1–6-branched N-
glycans. Thus, disrupting Gal1–N-glycan interactions may limit the
severity of chlamydial infection by inhibiting bacterial invasion of
host cells.
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The bacteria Chlamydia trachomatis (Ct) is the most commonagent responsible of sexually transmitted diseases worldwide
and the leading cause of infectious blindness in developing
countries (1). This pathogenic microorganism causes a broad
range of genitourinary diseases from mild acute infections to
chronic disorders with deleterious consequences for human health
and reproduction (2). As the majority of chlamydial genital in-
fections in women are asymptomatic, they often remain untreated,
leading to severe complications such as pelvic inflammatory dis-
ease, ectopic pregnancy, and tubal infertility (3). Additionally, Ct
may be a risk factor for cervical cancer (4). Hence, chlamydial
infections emerge as a public health concern of primary impor-
tance due to their high prevalence among young women and the
lack of an effective preventive vaccine.
Ct is an obligate intracellular bacterium whose natural hosts
are humans. Ct has a biphasic life cycle which alternates between
two distinct developmental forms: (i) the elementary body (EB),
a metabolically inert infectious form, and (ii) the reticulate body
(RB), a metabolically active but noninfectious replicative form.
After attachment and invasion of host epithelial cells, the EB
rapidly undergoes a transformation to the RB, which multiplies
by binary fission within the confines of a chlamydial-modified
phagosome, termed the inclusion. An increase of RBs triggers
differentiation back into EBs which are rapidly released to
disseminate infection into neighboring cells (5). A successful
intracellular infection relies on the ability of bacteria to ma-
nipulate the host cell molecular machinery to facilitate its entry
and invasion, as well as its capacity to avoid lysosomal degra-
dation and evade immune attack (5, 6). Given that the entire Ct
life cycle occurs intracellularly, a critical event for establishing
chlamydial infection is bacterial attachment, a two-step process
involving early reversible interactions followed by a high-
affinity irreversible association required for entry into host
cells. Multiple bacterial ligands and host receptors have been
implicated in Ct recognition and uptake (7), although the pre-
cise mechanisms underlying bacterial–host interactions are
still uncertain.
Initial studies showed that the Ct major outer membrane
protein (MOMP) binds to both mannose receptor and mannose
6-phosphate receptor, interactions that modulate infection in
vitro (8). In addition, the chlamydial outer membrane complex
protein B (OmcB) interacts with heparan sulfate proteoglycans
(9–11). Moreover, both MOMP and OmcB bind to glycosami-
noglycans, favoring synergistic electrostatic interactions required
to initiate invasion (12, 13). Furthermore, several chlamydial
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ligands have been shown to interact with glycosylated epithelial
receptors including β1 integrin, EphrinA2 receptor, platelet-derived
growth factor receptor (PDGFR)β, and fibroblast growth factor
receptor (FGFR) (14–17). However, despite considerable progress,
the endogenous mediators that link bacterial glycans and host re-
ceptors have not been identified.
Galectins, a family of endogenous glycan-binding proteins,
play pivotal roles in inflammation, immunity, and cancer by
modulating cell communication, signaling, adhesion, and mi-
gration (18–20). Emerging evidence suggests that galectins are
also involved in host–microbial recognition and pathogen sub-
version of immune responses (21–25). Galectin-1 (Gal1), a 14.5-kDa
member of this family, displays an evolutionary conserved
carbohydrate-recognition domain (CRD) which can homodi-
merize. Gal1 recognizes multiple β-D-galactopyranosyl-(1–4)-N-
acetyl-D-glucosamine (LacNAc) units, which are present on the
branches of N- or O-linked glycans and are created by the con-
certed action of specific glycosyltransferases. This includes the
N-acetylglucosaminyltransferase 5 (MGAT5), an enzyme that
generates β1–6-N-acetylglucosamine (β1–6GlcNAc)-branched
complex N-glycans, which are the preferred intermediates for
LacNAc extension (19). This prototype lectin has been impli-
cated in glycan-mediated recognition, invasion, and evasion by
various pathogens including parasites like Trypanosoma cruzi and
Trichomonas vaginalis (25–28) and viruses such as the human
T-cell leukemia virus-1, HIV-1, influenza virus, dengue virus,
Epstein–Barr virus, Nipah virus, and Enterovirus 71 (29–35).
With regards to bacterial infections, desialylation of airway epi-
thelial cells by neuraminidases enhances adhesion of Streptococcus
pneumoniae by facilitating Gal1 binding to specific glycans (36).
Moreover, we recently found that the enteropathogenic bacterium
Yersinia enterocolitica represses protective immune programs via
Gal1-dependent pathways (37). Furthermore, in a model of Pseu-
domonas aeruginosa infection, Gal1 suppresses corneal immuno-
pathology by limiting pathogenic Th17 responses (38). Interestingly,
several pathogenic bacteria including Helicobacter pylori can
themselves control genes involved in glycan biosynthesis, thus al-
tering sensitivity to bacterial adhesins and endogenous lectins (39).
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Fig. 1. Cell surface glycan profiles of Ct and HeLa
cells. (A) Lectin blot analysis of whole-cell lysates of Ct
infectious forms (EBs) detected with biotinylated lec-
tins followed by streptavidin-HRP. (B) Western blot
analysis of MOMP and OmcB expression in whole
bacterial cell lysates. (C) Glycophenotype of HeLa cells
detected with biotinylated lectins and PE-conjugated
streptavidin (filled curve) or incubated with PE-
conjugated streptavidin alone (control; empty curve)
analyzed by flow cytometry. In A and B blots are
representative of three independent experiments. In
C histograms are representative of three independent
experiments.
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Here, we identified a central role for Gal1–N-glycan interac-
tions in Ct recognition, attachment, and invasion of human
cervical epithelial cells and have validated the relevance of these
interactions in an experimental infection model in vivo. These
findings set the basis for developing Gal1-targeted strategies to
either prevent or attenuate chlamydial infection.
Results
Gal1 Binds to Ct and Host Cell Glycoproteins in a Glycan-Dependent
Fashion. To explore the impact of Gal1–glycan interactions in Ct
infection, we first assessed the glycophenotype of both the
chlamydial cell wall and cervical epithelial host cells using a
panel of biotinylated plant lectins. These proteins recognize
specific glycan epitopes, including those that are relevant for
Gal1 binding (SI Appendix, Table S1). Six lectins with different
glycan affinities were individually tested against proteins of
chlamydial EBs separated by SDS/PAGE (Fig. 1A). Lectin
blotting revealed the presence of high-mannose structures, as
indicated by Con A binding. Most intensely labeled are bands
migrating at 40 and 55 kDa, which are molecular weights (MW)
corresponding to MOMP and OmcB proteins (Fig. 1 A and B).
Moreover, both the 40- and 55-kDa bands bound Erythrina crista-
galli (ECL), a lectin capable of recognizing terminal N-ace-
tyllactosamine (LacNAc) in non-α2–6-sialylated complex N-gly-
cans and other glycoconjugates; only the 55-kDa band showed
high reactivity for L-phytohemagglutinin (L-PHA), a lectin spe-
cific for β1–6-branched complex N-glycans. Notably, probing
with Sambucus nigra agglutinin (SNA) demonstrated α2–6 sialy-
lation in several chlamydial glycoproteins in the range of 55–
70 kDa. Interestingly, no peanut agglutinin (PNA) reactivity was
observed, suggesting that chlamydial glycoproteins may not be
significantly enriched in asialo core-1 O-glycans (Fig. 1A and SI
Appendix, Table S2). These results suggest that, in addition to
well-known N-glycan high-mannose structures (40), a diverse
repertoire of LacNAc-enriched glycoproteins is present in Ct which
may serve as potential ligands for Gal1 binding. In this regard, α2–
6 sialylation, a glycan modification that prevents Gal1 binding, was
found in higher-MW glycoproteins (Fig. 1A), suggesting that
Gal1 recognition may be limited to proteins in the low-MW
range, such as MOMP and OmcB. Thus, Ct displays a broad
glycosylation profile that could differentially control Gal1 binding.
To characterize the glycan signature of human cervical epi-
thelial cells, we used HeLa cells as a model (41, 42). Cells were
collected and incubated with different biotinylated lectins (SI
Appendix, Table S1). Glycophenotypic analysis revealed high
frequency of glycans permissive for Gal1 binding as shown by
Lycopersicon esculentum- and ECL-reactive poly-LacNAc-enriched
glycan epitopes and β1–6-branched complex N-glycans de-
tected by L-PHA binding. Furthermore, we detected PNA-
reactive asialo core-1 O-glycans on the surface of HeLa
cells. Interestingly, α2–6-linked, but not α2–3-linked, sialic
acid was preferentially detected on HeLa cells as shown by
high SNA but undetectable Maackia amurensis agglutinin
staining (Fig. 1C). A broader characterization of glycosylated
ligands showed the presence of fucosylated structures on the
surface of these cells as detected by the fucose-binding lectins
Ulex europaeus agglutinin and Aleuria aurantia lectin, the
presence of terminal GalNAc by Helix pomatia agglutinin
binding, abundance of high-mannose structures determined by
Con A, and extensive exposure of bisecting GlcNAc residues
in N-glycans as evidenced by E-PHA recognition (Fig. 1C).
Furthermore, direct Gal1 binding to chlamydial glycoproteins
was determined by separating EB proteins by SDS/PAGE and
blotting with biotinylated Gal1. We confirmed reactivity of at
least six chlamydial glycoproteins recognized by Gal1, including
protein bands detected at 28, 37, 40, 42, 55, and 105 kDa (Fig.
2A). Moreover, Gal1 binding to HeLa cells was verified by lectin
cytometry using biotinylated Gal1 as a probe (Fig. 2B). To fur-
ther evaluate glycan-dependent binding of Gal1 to Ct cells, we
incubated isolated EBs with recombinant Gal1, centrifuged and
subsequently washed in the presence of lactose (100 mM) to
displace Gal1 binding (SI Appendix, Fig. S1). Each subsequent
pellet (EB+Gal1, EB1, and EB2) and eluted (E1) samples were
lysed and separated by SDS/PAGE (Fig. 2C). MOMP and
Gal1 were detected using specific polyclonal antibodies. Asso-
ciation of Gal1 with EBs was displaced by washing with lactose,
suggesting carbohydrate-dependent binding of this lectin to the
bacteria. Thus, Gal1 specifically associates with the surface of
both Ct and human cervical epithelial cells through glycan-
dependent mechanisms, suggesting a role for this lectin in
modulating Ct–host cell interactions.
Chlamydial Infection Modulates Gal1 Expression and Subcellular
Distribution in HeLa Cells. To understand the role of Gal1 during
Ct infection, we investigated the regulated expression of this
glycan-binding protein following exposure of HeLa cells to Ct
EBs. Endogenous Gal1 was analyzed by Western blot in un-
infected (control) and infected (Ct) host cells immediately after Ct
binding [0 h postinfection (pi)] and 1 h pi. Exposure to Ct resulted
in 40% increase in Gal1 protein content 1 h after chlamydial in-
fection (Fig. 2D). Moreover, Ct infection altered subcellular dis-
tribution of Gal1 from a uniform cytosolic and membrane-
associated pattern toward a membrane profile localized around
the chlamydial inclusion area within the infected cells (Fig. 2E).
This finding was confirmed by analysis of the distribution of en-
dogenous Gal1 (green) and DAPI-labeled bacteria (blue) along a
line traversing the chlamydial inclusion. Of note, whereas DAPI
labels both eukaryotic and bacterial DNA, chlamydial inclusions
(I) can be clearly distinguishable from nuclear (N) host DNA by
means of intensity and compartmentalization. Intensity profile
displayed two green peaks flanking the blue staining, indicating
the presence of Gal1 at the boundaries of the inclusion area
containing bacteria (Fig. 2E, Middle and Right). Furthermore, xz
and yz projections confirmed Gal1 recruitment to the chlamydial
inclusion area (Fig. 2F). This effect was further substantiated by
analysis of z-sections using confocal microscopy, revealing signif-
icant association of Gal1 with chlamydial inclusions. The different
optical planes revealed a fine punctuate pattern of endogenous
Gal1 surrounding the inclusion with DAPI-labeled bacteria inside.
Notably, Gal1 labeling was clearly detected within chlamydial in-
clusions (Movie S1). Thus, Ct infection modulates subcellular
compartmentalization of Gal1, suggesting a potential role for this
lectin in Ct–host cell interactions.
Gal1 Promotes Ct Attachment to Host Cervical Epithelial Cells.
Chlamydial invasion of host cells initially requires bacterial rec-
ognition and adhesion to the target cell surface (5). To examine
the impact of Gal1–glycan interactions on bacterial attachment
to host cells, we first incubated HeLa cells with an increasing
number of Ct (one or three bacteria per host cell) during the
binding step at 4 °C and washed cells thoroughly. A higher
number of adherent bacteria (evidenced by MOMP expression)
was accompanied by higher levels of endogenous Gal1 in whole-
cell lysates (Fig. 3A), suggesting a role for this lectin in modu-
lating the attachment process. To assess this effect directly, we
exposed HeLa cells to GFP-expressing Ct in the presence of
increasing concentrations of recombinant Gal1 (ranging from
0.1 to 5 μM) at 4 °C; this allows bacteria to attach yet prevents
their entry into host cells. Cells were washed extensively to
remove unbound bacteria and Gal1 and further incubated for
24 h at 37 °C to allow bacterial internalization and development
of chlamydial inclusions. The number of infected cells as well as
the magnitude of intracellular bacterial load was analyzed by
flow cytometry. Exposure to Gal1 significantly increased the per-
centage of infected cells in a dose-dependent manner, reaching a
plateau at 1 μM (Fig. 3B and SI Appendix, Fig. S2B). Accordingly,
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a maximum in target cell infection was attained at 1 μM Gal1
concentration, indicating that bacterial internalization is a receptor-
mediated process (Fig. 3C). Mean fluorescence intensity (MFI)
correlated with the extent of fluorescently labeled bacteria distrib-
uted within each individual target cell. Interestingly, the number of
bacteria per cell also increased following Gal1 exposure, likewise in
a dose-dependent fashion until a plateau was reached at 0.3 μM
(Fig. 3D). We conclude that extracellular Gal1 increases Ct adhe-
sion and entry into HeLa cells in a dose-dependent manner.
Typically, Gal1 occurs in a monomer–dimer equilibrium that
controls its biological activity. To investigate the contribution of
Gal1 dimerization to bacteria–host cell interactions, we used a stable
Gal1 variant (mGal1) generated by site-directed mutagenesis that
maintains its carbohydrate-binding activity but cannot dimerize at
the concentrations used (43). Addition of 1 μM mGal1 during
bacterial attachment at 4 °C was substantially less efficient in in-
creasing Ct adhesion and invasion of host cells compared with the
WT lectin (Fig. 3E). Moreover, the number of fluorescent bacteria
internalized per cell also dropped significantly when exposed to
mGal1 compared with WT Gal1 (1 μM) (Fig. 3F). These results
were further confirmed by confocal microscopy, which showed an
increased frequency of infected cells and a greater number of
chlamydial inclusions when bacteria were added to HeLa cells in the
presence of WT but not mutant mGal1 (Fig. 3G). Fig. 3G, Insets
show the size of chlamydial inclusions and the number of GFP-
labeled bacteria. Thus, Gal1 dimerization optimizes chlamydial ad-
hesion to host cells and likewise enhances bacterial infection.
Gal1 Facilitates Chlamydial Invasion of Host Cells. The ability of
Gal1 to bind to both chlamydial and host glycans prompted us to
analyze the contribution of this lectin to bacterial engulfment at
the ultrastructural level. Briefly, HeLa cells were incubated with
Ct in the absence or presence of 1 μM Gal1 at 4 °C (binding
step), then cells were washed and maintained at 37 °C for dif-
ferent pi periods (15 min or 2 h). Thereafter, cells were fixed and
processed for electron microscopy. Representative images are
shown in Fig. 4A. The presence of WT Gal1 induced an increase
in the number of chlamydial inclusions found in HeLa cells at 2 h
pi (Fig. 4 A and C) compared with cells infected under control
conditions (Fig. 4 A and B). However, addition of the mGal1 mu-
tant during the binding step was much less efficient than the WT
lectin in generating inclusion foci within infected cells (Fig. 4 A
and D). Furthermore, we found a significant increase in inclu-
sions containing two bacteria in cells incubated with WT Gal1
compared with those exposed to mGal1 or cultured in the ab-
sence of these lectins (Fig. 4E). To investigate this observation
further, we analyzed cells at very early stages of infection and
found nascent phagosomes including more than one Ct only
when infection occurred in the presence of the WT lectin (Fig.
4A). Taken together, these findings suggest that Gal1 not only
mediates bacterial adhesion to host glycans but may also pro-
mote Ct association, thus facilitating concomitant internaliza-
tion of more than one bacteria.
These results are in agreement with the increased number of
fluorescent bacteria per cell when cells were infected in the
presence of WT Gal1 (Fig. 3F). Thus, Gal1, mainly in its dimeric
form, facilitates bacterial internalization by engaging both chla-
mydial and host N-glycans.
Gal1 Enhances Chlamydial Adhesion to Host Cells Through Binding to
N-Glycosylated Receptors. To provide additional confirmation re-
garding N-glycans and their role in mediating Gal1-induced Ct
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attachment to host cells, we released complex N-glycans from the
surface of uninfected HeLa cells by enzymatic cleavage with
PNGase F. Flow cytometric analysis of L-PHA–stained cells con-
firmed a decrease in complex β1–6-branched N-glycans (Fig. 5A).
Loss of host N-glycans led to a significant reduction in the number
of Ct-infected HeLa cells (Fig. 5B), resulting in 50% reduction of
chlamydial infectivity (Fig. 5C). As α2–6 sialylation of terminal
LacNAc residues prevents Gal1 binding (44), we removed these
moieties from cell surface glycoproteins of HeLa cells using
neuraminidase A; loss of α2–6-linked sialic acid was confirmed by
elimination of SNA labeling (Fig. 5D). Neuraminidase A treat-
ment facilitated Gal1 binding and consequently enhanced chla-
mydial infection by ∼50% (Fig. 5 E and F). These results indicate
that Gal1 modulates binding and entry of Ct into human cervical
epithelial cells in an N-glycan–dependent fashion.
To explore further the mechanisms underlying Gal1-mediated
bacterial–host interactions, we next analyzed several N-linked
glycoproteins which have been proposed as candidate Ct recep-
tors (SI Appendix, Table S3) (45–48). We found substantial
colocalization of Gal1 and Ct antigens with both PDGFRβ and
β1/αVβ3 integrins when HeLa cells were exposed to the bacteria;
however, no significant overlapping could be detected among Ct,
Gal1, and FGFR2 (Fig. 5G). To assess the functional contribu-
tion of these receptors to Gal1-mediated chlamydial invasion, we
performed adhesion experiments in the absence or presence of
specific neutralizing antibodies. The number of green fluorescent
bacteria internalized per cell was measured by flow cytometry at
24 h pi. In agreement with the results of confocal microscopy,
blocking PDGFRβ or β1/αVβ3 integrins, but not FGFR2, signif-
icantly reduced the extent of bacterial infection promoted by
Gal1 (Fig. 5H). This inhibitory effect was less pronounced when
experiments were performed in the absence of exogenous Gal1
(SI Appendix, Fig. S2A). Thus, Gal1 promotes Ct invasion of host
cervical cells, at least in part, through N-glycosylation–dependent
interactions involving PDGFRβ and/or β1/αVβ3 integrins.
Gal1–N-Glycan Interactions Favor Ct Infection in Vitro and in Vivo. To
determine whether Gal1-mediated cross-linking of bacterial and
host N-glycans could enhance the extent of chlamydial infection,
we infected HeLa cells with green fluorescent Ct in the absence
or presence of Gal1 or its monomeric mutant mGal1. After 48 h,
internalized bacteria completed their developmental life cycle,
then chlamydial progeny was collected and its ability to infect
new cells was evaluated by confocal microscopy (Fig. 6A) and
flow cytometry (Fig. 6B). As shown by inclusion-forming units
assays, addition of WT Gal1 but not mGal1 generated a twofold
increase in the yield of infectious EBs (Fig. 6 A and B).
To evaluate the contribution of Gal1 to chlamydial infection in
vivo, we compared Ct infection of WT female mice in the pres-
ence or absence of recombinant Gal1 in an animal model
of genital infection. Briefly, female C57BL/6 mice were intra-
vaginally inoculated with green fluorescent Ct. At 14 d post-
inoculation (dpi), vaginal discharge was collected from each
mouse with disposable microbrushes and used to infect cell
cultures to assess the presence of chlamydial organisms. The
yield of infectious particles released from each infected mouse
correlated with the number and size of chlamydial inclusions
generated in HeLa cell monolayers as determined by confocal
microscopy (Fig. 6C). The number of fluorescent bacteria per
cell, indicated by MFI, was assessed by flow cytometry (Fig. 6C,
Insets). The addition of Gal1 during Ct challenge in vivo sig-
nificantly increased genital infection compared with WT mice in-
fected in the absence of the exogenous lectin. In agreement, the
number of bacteria per cell, indicated by MFI, significantly
augmented when vaginal discharges from mice infected in
A B C D
E F G
Fig. 3. Promotion of Ct adhesion and infection by Gal1. (A) Immunoblot analysis of endogenous Gal1 in HeLa cells incubated with different Ct numbers (MOI
1 and 3) during the binding step at 4 °C. Clathrin was used as loading control. (B–D) HeLa cells were infected with Ct (green) (MOI 0.5) in the presence of
increasing concentrations of recombinant Gal1 (0.1–5 μM) during the binding step at 4 °C and analyzed by flow cytometry. (B) Percentage of infected HeLa
cells at 24 h pi. (C) Fold increase in infection at 24 h pi. (D) Quantification of bacteria per cell measured by MFI at 24 h pi. (E–G) HeLa cells were infected with Ct
(green) in the absence or presence of 1 μM WT Gal1 or mGal1 during the binding step at 4 °C. (E) Fold increase in infection at 24 h pi analyzed by flow
cytometry. (F) Fold increase in the number of bacteria per cell determined by relative MFI at 24 h pi. In C, E, and F bars are the mean ± SEM (*P < 0.05, **P <
0.01, ***P < 0.001). (G) Representative micrographs of Ct-infected HeLa cells (green) by confocal microscopy. Arrowheads in insets indicate chlamydial in-
clusions. DNA was stained with DAPI (blue). (Scale bars, 10 μm.) N, nucleus. Data are representative of five independent experiments performed in triplicates,
except in A, where experiments were performed twice.
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the presence of exogenous Gal1 were assayed (Fig. 6C, Ct
vs. Gal1).
Given the modulatory effects of exogenous Gal1, we then
examined expression of this lectin in uteri from uninfected and
Ct-infected mice. Immunohistochemical analysis of uterine tissue
revealed significant up-regulation of Gal1 expression in response
to chlamydial infection (Fig. 6D). This effect was accompanied
by redistribution of this lectin, which shifted from a diffuse
stromal localization in uninfected mice toward a focalized
compartmentalization in simple columnar epithelium of Ct-in-
fected mice (Fig. 6D). These results are in agreement with those
observed in HeLa cells early after Ct infection (Fig. 2D).
To evaluate the impact of endogenous Gal1 and complex β1–
6-branched N-glycans during chlamydial infection, similar ex-
periments were performed in female mice lacking Gal1 (Lgals1−/−)
or MGAT5 (Mgat5−/−). Although vaginal discharges obtained
early after infection from Lgals1−/− and WT mice both generated
a low number of inclusions in HeLa cells ex vivo (Fig. 6C, Ct vs.
Lgals1−/− mice), immunoblot analysis of MOMP expression in
whole uteri homogenates revealed a significant lower degree of
Ct infection in Lgals1−/− vs. WT mice (Fig. 6E). Finally, vaginal
discharges collected from Mgat5−/− mice displayed a consider-
ably lower number of infectious Ct compared with WT mice (Fig.
6C, Ct vs. Mgat5−/−). These findings were reinforced by immu-
noblot analysis of MOMP expression in uterine tissue from
Mgat5−/− vs. WT infected hosts (Fig. 6E). Altogether, these re-
sults demonstrate the contribution of Gal1 as well as β1–6-
branched complex N-glycans to the pathophysiology of chla-
mydial infection in vivo.
Discussion
Chlamydia is an obligate intracellular bacterium that must bind
to epithelial host cells to initiate and establish infection (2). Host
invasion may involve bacterial adhesins recognizing host carbo-
hydrate moieties and host lectins interacting with bacterial gly-
coconjugates. Notably, chlamydial infectious forms (EBs) exhibit
diversity in their adhesion profiles, as demonstrated by glycan
arrays, capable of discriminating different Chlamydia species or
serovars (7, 49). In this regard, previous studies reported the
characterization of N-glycosylated proteins on the surface of Ct
(8, 40, 50), which play essential roles in the process of infection.
Inhibition of N-glycosylation with tunicamycin or specific cleav-
age of bacterial N-glycans decreased chlamydial infectivity (51).
However, these studies have focused primarily on the role of
high-mannose N-glycans and their interaction with host mannose-
binding proteins (40, 51). Here we demonstrated that chlamydial
membrane proteins of the infectious bacteria, particularly those
exhibiting low MW, display a distinctive glycosylation pattern that
is permissive for Gal1 binding.
Within the innate immune compartment, galectins are capable
of functioning as pattern recognition receptors that bind to
bacterial antigens and trigger complement activation, phagocy-
tosis, and adaptive immunity (20, 21). Here we show that
Gal1 binds to at least six chlamydial glycoproteins (gp28, gp37,
gp40, gp42, gp55, and gp105) and interacts with certain host
glycosylated receptors with permissive glycan structures for
Gal1 recognition, such as PDGFRβ and β1/αVβ3 integrins, sug-
gesting a novel role for this endogenous lectin in facilitating Ct
infection by bridging bacterial and host cell surface glycans. Al-
though we examined the involvement of well-established glyco-
sylated receptors in Ct invasion, our study does not exclude the
possibility that other cell surface glycoproteins may contribute to
this effect.
Given the bidirectional interaction of Gal1 with both chla-
mydial and host glycoproteins, we questioned whether this lectin
could act at the bacterial–host cell interface either by promoting
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Fig. 4. Ultrastructural analysis of Ct-infected HeLa
cells in the presence or absence of Gal1. (A) HeLa cells
were infected with Ct (MOI 1) in the absence or
presence of 1 μM Gal1 or mGal1 during the binding
step at 4 °C. Cells were fixed at 15 min pi (Right) or
2 h pi (Left andMiddle) and processed for transmission
electron microscopy. Arrowheads show chlamydial in-
clusions. (Middle and Right) Magnifications of chla-
mydial inclusions. (B–D) Percentage of HeLa cells
containing one or two Ct inclusions when incubated in
the absence (B) or in the presence of 1 μM Gal1 (C) or
mGal1 (D) during the binding step at 4 °C. (E) Per-
centage of Ct inclusions containing one or two bac-
teria in cells infected in the absence or in the presence
of 1 μMGal1 or mGal1 during the binding step at 4 °C.
Data are representative of two independent experi-
ments performed in duplicates.
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or inhibiting chlamydial adhesion and invasion. Our results
showed that incorporation of Gal1 during the recognition pro-
cess enhances chlamydial attachment to epithelial cells in a dose-
dependent manner, resulting in higher rates of infection. Nota-
bly, the number of infected cells reached a plateau, consistent
with chlamydial internalization as a receptor-mediated process.
Accordingly, Gal1 colocalized with PDGFRβ and β1/αVβ3 integ-
rins but not with FGFR2 at the bacterial–host cell boundaries
and blockade of these receptors attenuated the extent of in-
fection. In this regard, PDGFRβ blockade reduced binding of Ct
to target cells (16). Moreover, the Ct invasin Ctad1 associated with
β1 integrins to invade host cells (14). Thus, Gal1 may serve as a
bridge that connects glycosylated ligands present in both bacteria
and host cell receptors including PDGFRβ and β1/αVβ3 integrins.
Whereas FGFR2 has been reported to be a potential receptor for
Chlamydia infection (17), we could find no significant contribution
of this growth factor receptor to Gal1-mediated effects; these re-
sults could be due, at least in part, to the nonpermissive glyco-
sylation pattern of this particular receptor (45).
From a biochemical standpoint, Gal1 can form homodimers,
acquiring bivalent carbohydrate-binding capacity which enables
simultaneous cross-linking of glycosylated cell surface receptors
(19). Our findings indicate that Gal1 dimerization is critical to
promote optimal bacterial adhesion to target cells as the number
of bacteria internalized per cell increased considerably with the
addition of WT Gal1. Interestingly, although with much lower
potency, mGal1 also promoted Ct attachment to target cells,
suggesting the possibility that this monomeric mutant could in-
fluence dimer formation and/or cross-linking activity of the en-
dogenous lectin. Furthermore, it is possible to speculate that
Gal1 not only mediates chlamydial binding to host cells but also
induces bacterial clustering. In fact, Gal1 enhanced adhesion of
grouped Ct to host cells and increased the number of bacteria
internalized per cell, as shown by electron microscopy. Supporting
these findings, it has been demonstrated that Gal1 not only binds
to cervical epithelial cells but also agglutinates T. vaginalis (26).
The relevance of glycosylation in chlamydial attachment and in-
fection induced by Gal1 was confirmed by elimination of N-gly-
cans and desilalylation via enzymatic cleavage.
Since bacterial attachment to host cells is crucial for estab-
lishing chlamydial infection, we analyzed the impact of Gal1 on
the generation of bacterial progeny. Addition of Gal1 during Ct
binding resulted in a twofold increase in the yield of infectious
bacteria by enhancing chlamydial adhesion to and invasion of
HeLa cells. Although recombinant Gal1 was removed from ex-
tracellular media upon binding, an additional effect of Gal1 on
chlamydial replication could not be ruled out and warrants fur-
ther investigation. In agreement, intravaginal inoculation of mice
in the presence of recombinant Gal1 enhanced chlamydial in-
fection in vivo, as demonstrated by higher release of infectious
bacteria in the vaginal discharge and increased MOMP expression
in uterine tissue. Interestingly, Ct induced considerable up-regulation
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Fig. 5. Glycosylation-dependent Ct binding to host
cell receptors promotes infection. (A–C) HeLa cells
were pretreated with PNGase F to release N-glycans.
(A) Analysis of L-PHA binding to untreated or
PNGase F-treated cells by flow cytometry. (B) Per-
centage of infected HeLa cells determined by flow
cytometry. (C) Fold decrease of Ct infection in
PNGase F-treated cells. (D–F) HeLa cells were treated
with neuraminidase A (Neu A) to release sialic acid.
(D) Analysis of SNA binding to untreated and Neu A-
treated cells by flow cytometry. (E) Percentage of
infected HeLa cells by flow cytometry. (F) Fold in-
crease of Ct infection in Neu A-treated cells. (G)
Immunofluorescence detection of N-glycosylated re-
ceptors on HeLa cells incubated with Ct during the
binding step at 4 °C (MOI 3). Infection was confirmed
using an anti-MOMP antibody (blue). FGFR2, PDGFRβ,
β1-integrin, and αVβ3 integrins were detected using
specific antibodies (red). Gal1 was detected using a
rabbit anti-human Gal1 antibody (green). Arrowheads
indicate triple colocalization. (Scale bars, 10 μm.) (H)
Contribution of glycosylated receptors to Gal1-induced
Ct infection. Quantification of bacteria per cell mea-
sured by MFI at 24 h pi in HeLa cells incubated with
1 μM recombinant Gal1 in the absence or presence
of different neutralizing monoclonal antibodies. In
B, C, E, F, and H data are the mean ± SEM of three
experiments (**P < 0.01, ***P < 0.001). In A, D, and
G data are representative of three independent ex-
periments performed in triplicates.
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of endogenous Gal1 both in vitro and in vivo, supporting a critical
role for this lectin in modulating infection. Accordingly, uterine tissue
from Gal1-deficient mice presented lower bacterial load as demon-
strated by diminished levels of MOMP expression, although these
differences could not be verified in vaginal discharges, probably due
to the low sensitivity of this assay. Moreover,Mgat5−/−mice generated
fewer infectious progeny, thus confirming the role of complex β1–6
branched N-glycans in chlamydial infection outcome. As several
galectin family members may recognize LacNAc-enriched complex
branched N-glycans (19), these findings may reflect the contribution
of other galectins to Ct–host cell interactions.
Interestingly, we detected an initial increase of Gal1 expression
in Ct-infected cells and striking changes in subcellular distribution
of this lectin shifting from a broad cytosolic and membrane-
associated pattern toward the formation of chlamydial inclusions
in vitro. Furthermore, Ct infection in vivo led to changes in Gal1
distribution which turned from a stromal localization toward a
columnar epithelial compartmentalization in uterine tissue. Like-
wise, Gal1 was found to be up-regulated and relocalized in re-
sponse to infection with different types of bacteria, viruses, and
parasites (21, 52).
Although a role of Gal1 in inducing attachment of viruses and
parasites to human cells has been reported, there is still scarce
information on the contribution of Gal1 to bacterial infections.
Previous reports showed that Gal1 promotes binding of viral
envelope gp120 to CD4+ T cells, facilitating HIV-1 infection in a
β-galactoside–dependent manner (30). Also, Gal1 promotes
enterovirus 71 replication and enhances its infectivity (34). In
contrast, Gal1 binding to N-linked oligosaccharides of hemag-
glutinin and neuraminidase from influenza virus masks relevant
glycan structures and inhibits viral infection (31). Similarly,
Gal1 inhibits dengue virus adsorption and internalization into
target cells (32). However, Gal1 favors Nipah virus attachment to
endothelial cells but inhibits the fusion of its envelope glycopro-
teins with target cells (33). Additionally, interactions between
T. vaginalis lipophosphoglycan and Gal1 have been reported to
control parasite infection of human cervical epithelial cells (26).
Furthermore, low concentrations of Gal1 enhanced T. cruzi rep-
lication, whereas higher levels of this lectin inhibited this process
(27, 28, 53). Regarding bacterial infections, Gal4 and Gal8, two-
CRD galectins, have been shown to recognize and kill bacteria-
expressing B− blood group antigens on their surface (54). Finally,
pathogenic bacteria may also subvert recognition of host galectins
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Fig. 6. Gal1 promotes chlamydial infection in vitro
and in vivo. (A and B) HeLa cells were infected with
Ct (green) (MOI 0.5) in the absence or presence of
1 μM recombinant Gal1 or mGal1. At the end of
chlamydial developmental cycle (48 h pi), infected
cells were lysed and the infectious particles were ti-
trated in serial dilutions on HeLa cell monolayers. (A)
Confocal microscopy of inclusions generated by
progenies collected from chlamydial control (Ct),
Gal1-treated, and mGal1-treated HeLa cells. Repre-
sentative images show the inclusions (green) de-
veloped at 24 h pi. DNA was stained with DAPI
(blue). Arrowheads indicate chlamydial inclusions.
(Scale bars, 10 μm.) (B) Number of relative IFU (rIFU)
generated by chlamydial progenies determined by
flow cytometry (*P < 0.05). (C and D) Development
of Ct infection in vivo. Female C57BL/6 mice were
intravaginally infected with fluorescent Ct in the
absence (Ct; n = 10) or presence of 1 μM recombi-
nant Gal1 (Gal1; n = 10). Mice lacking Gal1 (Lgals1−/−;
n = 10) or MGAT5 (Mgat5−/−; n = 5) were infected
with Ct. At 14 dpi vaginal discharges were collected.
(C) Confocal microscopy of inclusions (green) gen-
erated in HeLa cell monolayers exposed for 24 h pi to
mice vaginal discharges. (Insets) Magnifications of
the selected areas. MFI represents fluorescent in-
tensity of bacterial inclusion determined by flow
cytometry. (Scale bars, 10 μm.) (D) Immunohisto-
chemical analysis of Gal1 expression in uteri sections
from uninfected and Ct-infected mice. (Scale bars,
50 μm.) (E) Immunoblot analysis of bacterial MOMP
in uterine tissue from chlamydial control (Ct), Gal1-
treated, Lgals1−/−, or Mgat5−/− mice. β-actin was
used as loading control. Data are the mean ± SEM (B)
or are representative (A and C–E) of three in-
dependent experiments.
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to ensure successful attachment and invasion of target cells leading
to alteration of immune responses (37).
In conclusion, our study utilizes both in vitro and in vivo
strategies to demonstrate that Gal1 favors the development of
productive chlamydial infections by modulating attachment
and internalization of bacteria into host cells via an N-glycan–
dependent mechanism. In support of our findings, other sex-
ually transmitted pathogens, including HIV-1 and T. vaginalis,
exploit Gal1 as a critical mediator responsible of promoting
infection (26, 30). As preexisting sexually transmitted diseases
are significant risk factors for other sexually transmitted
pathogens (including HIV-1), further studies should explore
the relevance of Gal1 as a critical endogenous factor medi-
ating coinfection. Thus, Gal1-specific antagonists (55) could
be useful as a means to undermine chlamydial infection as well
as other STDs. Understanding the role of galectin–glycan in-
teractions at the pathogen–host cell interface may lead to
development of novel therapeutic approaches aimed at at-
tenuating bacterial infections.
Materials and Methods
Cell Culture, Antibodies, Recombinant Galectins, and Reagents. HeLa
229 cells were cultured in high glucose Dulbecco’s modified Eagle’s me-
dium (Gibco BRL) supplemented with 10% (vol/vol) FBS (Internegocios
SA), 0.3 mg/mL L-glutamine (ICN Biomedicals Inc.), and 1.55 mg/mL glu-
cose (Biopack) without antibiotics in 5% CO2 at 37 °C. Primary, neutral-
izing, and secondary antibodies used for blocking and labeling are listed
in SI Appendix, Table S3. Recombinant Gal1 and the mGal1 variant were
produced and purified as described (56, 57). Lipopolysaccharide content
of the purified samples (<60 ng/mg) was tested using a Gel Clot Limulus
Test (Cape Cod).
Bacterial Strains. Ct serovar L2 and Ct-transformed strain harboring p2TK2-
SW2 IncD Prom-RSGFP-IncDTerm (GFP-overexpressing Ct L2) were generated
and kindly provided by H. Agaisse and I. Derré, Yale University School of
Medicine, New Haven, CT (58). Bacterial propagation was performed as
described in SI Appendix. Aliquots were stored at −80 °C and thawed im-
mediately before use.
Glycophenotype Analysis. HeLa cells were incubated with biotinylated lectins
listed in SI Appendix, Table S1 as described (44). Flow cytometry analysis was
performed using a BD FACSAria III (Becton Dickinson Biosciences). A mini-
mum of 10,000 gated events were collected for each sample. Data were
analyzed using FlowJo software.
For lectin blotting, 1 × 106 Ct were lysed (50 mM Tris, 150 mM NaCl,
10 mM EDTA, and 1% Nonidet P-40), solved in 10% SDS/PAGE, and trans-
ferred onto a 0.45-μm nitrocellulose membranes (GE Healthcare Life Sci-
ence). Strips were probed with different biotinylated lectins as indicated
(44). Immunoreactivity was visualized using horseradish rabbit peroxidase
(HRP)-conjugated streptavidin (Sigma) and Pierce ECL Western blotting
substrate (Thermo Fisher Scientific Inc) with an ImageQuant LAS 4000 (GE
Healthcare Life Science).
Gal1 Binding and Deglycosylation Assays. Carbohydrate-dependent Ct bind-
ing assays were performed as described in SI Appendix (SI Appendix, Fig. S1).
All bacterial pellets (EB, EB1, and EB2) and eluate (E1) were resolved on a
15% SDS/PAGE, transferred onto 0.45-μm nitrocellulose membranes (GE
Healthcare), and incubated overnight with anti-Gal1 (1:1,000) or anti-MOMP
(1:500) antibodies followed by goat anti-rabbit HRP-conjugated IgG (1:5,000,
1 h, 37 °C). Protein bands were visualized using Pierce ECL Western blotting
substrate in an ImageQuant LAS 4000.
To examine the role of glycans in Gal1 effects, HeLa cells (1 × 105) were
incubated with PNGase F (50 U, 37 °C, 4 h), α2–3/6/8/9 neuraminidase A (20
U, 37 °C, 1 h) (New England Biolabs), or 30 mM lactose (Sigma) before
infection with fluorescent Ct. At 24 h pi, cells were gently detached using
trypsin and stained with 30 μL propidium iodide (1:1,000). Cells were an-
alyzed by flow cytometry.
Ct Binding to Host Cells and Receptor Neutralization Assays. HeLa cells (1 × 105
cells/well) were preincubated in the absence or presence of recombinant
Gal1 or its stable monomeric mutant mGal1 at different concentrations
(0.1–5 μM) at 4 °C before addition of green fluorescent Ct [multiplicity of
infection (MOI) 0.5]. Then, Ct was added to plates which were centrifuged at
400 × g for 15 min at 4 °C (binding step). Then, cells were washed three times
with 500 μL cold PBS to remove unbound bacteria and the excess of Gal1.
Finally, cells were incubated for 24 h in 5% CO2 at 37 °C (infection period)
and analyzed by flow cytometry as indicated above.
To study the involvement of N-glycosylated receptors, HeLa cells were
incubated 30 min at 37 °C in the absence or presence of recombinant
Gal1 and neutralizing antibodies to FGFR2 (0.5 μg/mL), PDGFRβ (20 μg/mL), β1
integrin (10 μg/mL), and β1/αVβ3 integrins (10 μg/mL) before infection with
fluorescent Ct. Then, cells were analyzed by flow cytometry at 24 h pi to
determine the amount of bacteria within each cell.
Immunoblotting. Immunoblot analysis was performed essentially as described
(44). Briefly, equal amounts of protein were resolved by SDS/PAGE, trans-
ferred onto 0.45-μm nitrocellulose membranes, and incubated overnight
with anti-MOMP (1:500), anti-Gal1 (1:1,000) and anti–β-actin (1:1,000) anti-
bodies followed by goat anti-rabbit HRP-conjugated IgG (1:5,000, 1 h, 37 °C).
Bands were visualized using Pierce ECL Western blotting substrate in an
ImageQuant LAS 4000.
Immunofluorescence and Immunohistochemistry. HeLa cells (1 × 105 cells per
well) grown on coverslips were infected with Ct for different time periods.
To identify endogenous proteins, cells were fixed with 3% paraformalde-
hyde, quenched, and incubated with the appropriate primary antibodies
followed by fluorescently labeled secondary IgG. Coverslips were mounted
in Mowiol 4-88 with 0.5 μg/mL DAPI for DNA staining. Samples were ob-
served under an Olympus FluoView FV1000 confocal microscope equipped
with multiple filter sets. Images were processed using ImageJ software. For
immunoperoxidase, paraffin-embedded uterine tissue sections were
stained with rabbit anti-Gal1 IgG as described (59) using the Vectastain
Elite ABC kit (Vector).
Transmission Electron Microscopy. HeLa cells were grown in T-25 flasks,
infected with Ct (MOI 5), and fixed at 15 min or 2 h pi with 2.5% glu-
taraldehyde in 0.1 M sodium cacodylate buffer and processed as de-
scribed in SI Appendix. Grids were examined with a Zeiss 900 electron
microscope (Zeiss).
IFU Assay. To evaluate the effects of Gal1 on chlamydial replication, HeLa cells
were preincubated with or without 1 μM recombinant Gal1 or mGal1 at 4 °C
before addition of fluorescent Ct (MOI 0.5) and processed as described in
SI Appendix.
Chlamydial Genital Infection in Mice. Six-week-old C57BL/6 female mice were
bred and maintained under specific pathogen-free conditions. Animal
protocols were approved by the Committee of Animal Care and Use
Guidelines of the Faculty of Medicine, National University of Cuyo (CICUAL,
FCM, UNCuyo). Lgals1−/− mice were provided by F. Poirier, Jacques Monod
Institute, Paris, and Mgat5−/− mice were obtained from Jackson’s Labora-
tories. To synchronize the murine estrous cycle, a single dose of 2.5 mg
medroxyprogesterone acetate (Holliday Scott SA) was s.c. injected in each
mouse 7 d before inoculation with Ct. Mice were divided into four groups:
(i) Ct (n = 10) inoculated in WT mice; (ii ) Ct inoculated in WT mice in the
presence of 1 μM recombinant Gal1 (Ct + Gal1; n = 10); (iii) Ct inoculated in
Lgals1−/− mice (n = 10); and (iv) Ct inoculated in Mgat5−/− mice (n = 5).
Animals were inoculated intravaginally with 1.5 × 105 EBs under ketamine
(Holliday Scott SA) and xylazine (König SA) anesthesia.
Analysis of Chlamydial Progenies Released in Vaginal Discharges. Vaginal dis-
charges were collected with disposable microapplicators (Multi-Brush; Denbur
Inc.) at 14 dpi and used for infectingHeLa cell monolayers grown on coverslips
in 24-well plates for 48 h in the presence of gentamicin 50 μg/mL and pro-
cessed as described in SI Appendix. Determinations were performed in three
independent experiments in triplicates. Vaginal discharges were collected
from two independent genital infection assays.
Statistical Analysis. Statistical analysis was performed using GraphPad Prism
5.0 Software (GraphPad). Data represent the mean ± SDs of N experiments.
For simple unpaired analysis between two groups, Student’s t test was
chosen. For multiple comparisons, ANOVA with subsequent Bonferroni’s
or Dunnet’s posttests was used. P values less than 0.05 were considered
statistically significant.
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